Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice - Wikidata - awgldk - TriplyDB

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

http://www.wikidata.org/entity/Q33810234

about

The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis Redox balance dynamically regulates vascular growth and remodeling Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines Fatty acid conjugates of water-soluble (±)-trans-Selenolane-3,4-diol: effects of alkyl chain length on the antioxidant capacity.Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis.Mouse Models of Oxidative Stress Indicate a Role for Modulating Healthy Aging.Helminth infection in populations undergoing epidemiological transition: a friend or foe?Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells.Tuning of peroxiredoxin catalysis for various physiological roles Peroxiredoxin II is an antioxidant enzyme that negatively regulates collagen-stimulated platelet function Heme oxygenase-1, oxidation, inflammation, and atherosclerosis Interaction between the Stress Phase Angle (SPA) and the Oscillatory Shear Index (OSI) Affects Endothelial Cell Gene Expression.Intermittent Hypoxia-Induced Carotid Body Chemosensory Potentiation and Hypertension Are Critically Dependent on Peroxynitrite Formation Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease.Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.Cell stress proteins in atherothrombosis Molecular biology of atherosclerosis.Are reactive oxygen species still the basis for diabetic complications?ROS signaling and redox biology in endothelial cells.The impact of thiol peroxidases on redox regulation.Discovering Antioxidant Molecules in the Archaea Domain: Peroxiredoxin Bcp1 from Sulfolobus solfataricus Protects H9c2 Cardiomyoblasts from Oxidative Stress.Upregulation of Dickkopf1 by oscillatory shear stress accelerates atherogenesis.Responses to reductive stress in the cardiovascular system.Epigenetic alterations in patients with type 2 diabetes mellitus Targeting endogenous antioxidants to prevent cardiovascular diseases Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.The absence of macrophage Nrf2 promotes early atherogenesis.Citreoviridin enhances tumor necrosis factor-α-induced adhesion of human umbilical vein endothelial cells.Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux.Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation.Raspberry differentially improves age-related declines in psychomotor function dependent on baseline motor ability.Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro.Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men Monitoring the action of redox-directed cancer therapeutics using a human peroxiredoxin-2-based probe

P2860

Q24605439-C3E7ADDD-C701-4EF7-8A25-B4AF12384484 Q27004547-97800487-459A-4BB5-B371-6DD31F193993 Q28071377-B6D97576-1D6F-42B9-B1C5-97056A523F6C Q28389739-5E8C765A-DA47-4C10-84CC-48B6F242F303 Q28392715-9C18924D-EB72-4F21-A8C7-5E5A5506F45E Q28481323-07CC9EAC-8FCB-4526-A127-4853BED3D615 Q30934420-AB84D0BA-9616-4423-B201-EB839F656294 Q33808269-858DE0E3-9E1D-4FD8-8C3E-084EF297403A Q34300952-248E14F5-FD66-4AAA-A84D-01D236DCDAEC Q34467996-951FEAFE-EFBD-46D3-AE3C-0B0B91658BE8 Q34550490-0FB17AF0-5AEB-4265-BCD3-932E883BE0F9 Q34731736-52D920EF-E696-4FB1-AC19-845EF1D18239 Q35561016-C9920296-F7A4-48A7-A5AF-21205D23F35A Q36103851-C7263A46-F8D8-4C6C-98E5-0820989EBFCE Q36192815-702536C2-9507-4A78-969B-22D012A1F439 Q36424244-8F2B6AA4-5C8F-4E17-8958-ABC18CCF253D Q37145594-99D3FB75-6F46-42C4-AD02-C14C86DFA8DC Q37601145-375970A3-0169-4930-B946-CD5976FE58B7 Q37624935-EA452C13-94AC-4D08-80AA-338842F079D9 Q38026043-75512FCE-C60D-436E-A0C0-99144E318BFE Q38125279-3284AED2-AAE5-4C12-94F0-5A39C6AFBA92 Q38451253-EB8C1C4E-3F25-407E-BA75-019824929EAD Q38478574-38C9EDF5-9EA0-465B-BF90-2AACFD58AA89 Q38570138-31338884-A753-4D06-BEBF-7624D10D58A7 Q38740353-24F79536-24EC-468A-A0C4-393F9E3E7EAE Q38816713-7C69895D-9488-4908-AE9F-CB29C5379404 Q39035367-41408158-084E-4ECD-BCB2-3FC3A79E1100 Q41110363-3EDA959B-2906-4526-8470-19AE58978AF9 Q42588905-ADE068BE-5371-4992-9040-4F5173894F6E Q42819139-3D92CCF1-2087-495B-B789-7E590ED8E6B2 Q43901244-632A0268-9704-486F-9C78-0579287D6E50 Q44778714-6B92ECE9-D9FC-4F7F-B4C9-E3BC65D8AD69 Q45981930-5C544BB6-0CA7-4C22-A03E-8E0C4A7AEC36 Q46266568-D0D5EACB-9FF3-4F8C-A37E-8A275EA3603F Q49714845-F8A0A7C9-CAE9-438F-A492-506D41BC3B80 Q50247547-E66C6F31-43A6-4197-B6A0-DFBB33D1E755 Q57921499-088D877E-D67A-4FE0-AD2D-49934A2BFDD1 Q58797739-C65C22B3-0E9A-4861-890D-ABDC34777418

P2860

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

http://www.wikidata.org/entity/Q33810234

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

@ast

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

@en

type

label

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

@ast

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

@en

prefLabel

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

@ast

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

@en

P1433

Q33810234-D6DDCACE-7009-484C-A808-91361104D3C0

P1476

Q33810234-C5E3D847-8C65-4419-B6E3-86A80FC99161

P2093

Q33810234-376F54C5-E764-4D9F-A7BE-30E85C77DA72

Q33810234-3C63B5AF-9C64-4B67-B722-E4127CA4938F

Q33810234-5D0AE641-A839-4B89-9283-668D078E79C1

Q33810234-5F601390-3A99-4D94-A8C0-2A756B36C64E

Q33810234-6957EE42-2614-4043-84B4-90CF01EAB88E

Q33810234-76B66EAE-8B66-422C-85ED-AC47B3C7231D

Q33810234-8B785DC0-AB98-4635-9435-AA7BA4B8A25F

Q33810234-9AD8C230-2AFA-4061-8ECF-747D2E44568F

Q33810234-A402D2F6-D318-4539-B96A-D5701DB2CC2E

Q33810234-D954F678-75D6-4901-8E19-12337EDAC3A3

P2860

Q33810234-05228A53-576E-46F6-B682-445C5C6274BD

Q33810234-074553F3-C836-4DB6-A786-5BABEC045744

Q33810234-11B2D5AA-4944-4672-912A-4EFC5281CE41

Q33810234-120D4E88-ECA3-42D8-BB95-77F7756245D8

Q33810234-1EFBCC03-C7B5-4912-B251-DE274BBF48E2

Q33810234-28001FB3-31C1-484C-A153-86FEB2147311

Q33810234-294DA3E0-7EBF-479A-9473-2EA7FF77CEC9

Q33810234-316A50DE-F051-4064-8C8D-4D4FEF3D7E44

Q33810234-35894D2D-74A4-4B8B-9F70-10BCD85BB612

Q33810234-39384ED9-96E2-4CD8-853F-194BBD35211E

P304

Q33810234-4454720A-6075-431A-B146-0523E9A4F284

P31

Q33810234-8431A128-29E8-48F3-B683-3F6FA211C95F

P356

Q33810234-B949ABD3-D9C4-4E59-BC16-71DCB4508885

P433

Q33810234-A2A28CD7-404D-4F68-8F98-FED894720D42

P478

Q33810234-56FE6471-7813-455D-943C-22B71BAC4D6B

P50

Q33810234-CF1254AA-33AB-40AA-A42A-C3605F0D0101

P577

Q33810234-D7A9C586-EA01-4B91-880D-393C737A96FB

P698

Q33810234-F03C934A-3689-4A4E-A2E2-2EA581C03445

P921

Q33810234-9E45D9BD-5246-4B5A-9C81-E62895709168

P932

Q33810234-7F537C17-78D4-4642-BD34-B44D0E714B4E

P356

CIRCRESAHA.111.245530

P1433

Circulation Research

P1476

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

@en

P2093

Dae-Yeul Yu

http://www.w3.org/2001/XMLSchema#string

Goo Taeg Oh

http://www.w3.org/2001/XMLSchema#string

Hyoung Chin Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Hoon Choi

http://www.w3.org/2001/XMLSchema#string

Jeong Hwa Lee

http://www.w3.org/2001/XMLSchema#string

Ji-Young Yoo

http://www.w3.org/2001/XMLSchema#string

Jong-Gil Park

http://www.w3.org/2001/XMLSchema#string

Mi-Ni Lee

http://www.w3.org/2001/XMLSchema#string

Mi-Ran Lee

http://www.w3.org/2001/XMLSchema#string

Mun-Han Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease

Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

Dual role of peroxiredoxin I in macrophage-derived foam cells

Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II

T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene

Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock

Adhesion molecules and atherogenesis.

Vascular adhesion molecules in atherosclerosis.

Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice.

P304

739-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.111.245530

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21835911

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5474748

http://www.w3.org/2001/XMLSchema#string